Prognostic value of perfusion MR imaging in patients with oligodendroglioma: A survival study;Valeur pronostique de l'IRM de perfusion chez les patients avec oligodendrogliome: Une étude de survie

Journal of Neuroradiology

Volumn 38, Issue 1, 2011, Pages 53-61

  Jiang, Z ^a,b,c,d   Le Bas, J F ^a,b   Grand, S ^a,b   Salon, C ^a   Pasteris, C ^a   Hoffmann, D ^a   Bing, F ^a   Berger, F ^a,b   Chabardes, S ^a   Liu, C ^c,d   Krainik, A ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^c THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Cerebral tumour; Oligodendroglioma; Perfusion MRI; Survival prognosis

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM;

ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIXED TUMOR; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PATIENT CODING; PROGNOSIS; SURVIVAL TIME; TUMOR BIOPSY; TUMOR VOLUME; VALIDATION PROCESS;

ADULT; AGED; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BRAIN; BRAIN NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 79952737538     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurad.2010.03.004     Document Type: Article

References (26)

1. Daumas-Duport C., Varlet P., Tucker M.L., et al. Oligodendrogliomas. Part I: patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 1997, 34(1):37-59.
2. Engelhard H.H., Stelea A., Mundt A. Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis. Surg Neurol 2003, 60(5):443-456.
3. Brami-Zylberberg F., Grand S., Le Bas J.F., et al. MRI for oligodendrogliomas. Neurochirurgie 2005, 51(3-4 Pt 2):273-285.
4. Aronen H.J., Gazit I.E., Louis D.N., et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994, 191(1):41-51.
5. Kremer S., Grand S., Remy C., et al. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002, 29(2):105-113.
6. Leon S.P., Folkerth R.D., Black P.M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996, 77(2):362-372.
7. Mills S.J., Patankar T.A., Haroon H.A., et al. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?. AJNR Am J Neuroradiol 2006, 27(4):853-858.
8. Law M., Oh S., Babb J.S., et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging - prediction of patient clinical response. Radiology 2006, 238(2):658-667.
9. Lev M.H., Ozsunar Y., Henson J.W., et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004, 25(2):214-221. [corrected].
10. Law M., Young R.J., Babb J.S., et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008, 247(2):490-498.
11. Hirai T., Murakami R., Nakamura H., et al. Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. AJNR Am J Neuroradiol 2008, 29(8):1505-1510.
12. Le Bas J.F., Grand S., Kremer S., et al. Perfusion MR imaging for initial diagnosis and follow-up of brain tumors. Neurochirurgie 2005, 51(3-4 Pt 2):287-298.
13. Le Bas J.F., Grand S., Krainik A., et al. Perfusion MR imaging in brain tumors. J Radiol 2006, 87(6 Pt 2):807-821.
14. Wetzel S.G., Cha S., Johnson G., et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002, 224(3):797-803.
15. Louis D.N., Ohgaki H., Wiestler O.D., et al. WHO classification of Tumours of the Central Nervous System. 2007, IARC, Lyon.
16. Daumas-Duport C., Tucker M.L., Kolles H., et al. Oligodendrogliomas. Part II: a new grading system based on morphological and imaging criteria. J Neurooncol 1997, 34(1):61-78.
17. Brasil Caseiras G., Ciccarelli O., Altmann D.R., et al. Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology 2009, 253(2):505-512.
18. Cha S., Tihan T., Crawford F., et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2005, 26(2):266-273.
19. Shinojima N., Kochi M., Hamada J., et al. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J Neurosurg 2004, 101(2):219-226.
20. Burton E.C., Lamborn K.R., Forsyth P., et al. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res 2002, 8(1):180-187.
21. Jackson R.J., Fuller G.N., Abi-Said D., et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 2001, 3(3):193-200.
22. Ginsberg L.E., Fuller G.N., Hashmi M., et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998, 49(4):436-440.
23. Boxerman J.L., Schmainda K.M., Weisskoff R.M. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006, 27(4):859-867.
24. Spampinato M.V., Wooten C., Dorlon M., et al. Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors. Neuroradiology 2006, 48(12):867-874.
25. Wirestam R., Andersson L., Ostergaard L., et al. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med 2000, 43(5):691-700.
26. Bleeker E.J., van Buchem M.A., van Osch M.J. Optimal location for arterial input function measurements near the middle cerebral artery in first-pass perfusion MRI. J Cereb Blood Flow Metab 2009, 29(4):840-852.